You are currently viewing a new version of our website. To view the old version click .

Designing New Antimicrobials Based on Known Valuable Heterocycles as Building Blocks

Topic Information

Dear Colleagues,

Heterocycles are essential structural components in various antimicrobial drugs. The significance of heterocycles in drug design resides in their ability to modify the drug candidate’s physicochemical characteristics, biological impact, and pharmacokinetic and toxicological profile. Numerous recent studies have targeted therapeutic agents with heterocycle-based structures. In the last decade, diverse heterocyclic compounds have been synthesized to develop new antimicrobials capable of treating bacterial, viral, fungal, or parasitic infections. The physicochemical properties imparted by a heterocycle are associated with the biological activity of the drug (the spectrum of activity and potency) and its pharmacokinetic, pharmacologic, and toxicological profiles. Highlighting the relationships between heterocycles in the molecular structure of antimicrobial drugs and their biological properties can serve as the basis for many other rational design studies for discovering new antimicrobials (antibiotics, antivirals, antifungals, and antiparasitics). Incorporating valuable heterocycles into the molecular structure of antimicrobials represents a promising avenue for advancing drug development. It offers opportunities to enhance drug efficacy, safety, and diversity, which is crucial in the ongoing battle with infections, parasitosis, and resistance to antimicrobials. As a result of drug resistance in bacteria, fungi, HIV, tuberculosis, malaria, and tropical diseases, antibiotics and other antimicrobial drugs become ineffective, and infections become difficult or impossible to treat, increasing the risk of disease, severe illness, disability, and death.

This Topic focuses on the rational design of novel antimicrobials by leveraging the structural diversity and pharmacological potential of known valuable heterocycles as fundamental building blocks. Continued research is essential to translate all promising findings into effective treatments that benefit global public health. The proposed Topic aims to identify the latest trends in discovering new antimicrobials based on valuable heterocycles as building blocks and will welcome both research papers and reviews.

Prof. Dr. Aura Rusu
Prof. Dr. Gabriel Hancu
Dr. Vladimír Garaj
Topic Editors

Keywords

  • antimicrobials
  • heterocycles
  • drug design
  • antibiotics
  • antibacterials
  • antifungals
  • antivirals
  • antimalarials
  • anti-infective agents
  • antimicrobial resistance
Graphical abstract

Participating Journals

Antibiotics
Open Access
9,218 Articles
Launched in 2012
4.6Impact Factor
8.7CiteScore
15 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
International Journal of Molecular Sciences
Open Access
106,484 Articles
Launched in 2000
4.9Impact Factor
9.0CiteScore
20 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Molecules
Open Access
62,434 Articles
Launched in 1996
4.6Impact Factor
8.6CiteScore
16 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
Pharmaceutics
Open Access
13,701 Articles
Launched in 2009
5.5Impact Factor
10.0CiteScore
15 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Scientia Pharmaceutica
Open Access
1,574 Articles
Launched in 1930
2.5Impact Factor
4.6CiteScore
38 DaysMedian Time to First Decision
Q3Highest JCR Category Ranking
Biophysica
Open Access
239 Articles
Launched in 2021
1.4Impact Factor
2.3CiteScore
23 DaysMedian Time to First Decision
Q4Highest JCR Category Ranking

Published Papers